Web Flow - Login to access your portal

Safety Success at Tredegar for Sixth Year Running

We have maintained our consistent safety track record, having operated without a single reportable accident at its manufacturing facility in Tredegar, South Wales for the last six years.

The milestone is a significant industry achievement for PCI: it equates to over three million working hours delivered by an average of 300 staff during this six year period. The site provides the global healthcare industry with fully integrated development and manufacturing services, ranging from early phase formulation and analytical development through to commercial manufacture, packaging and commercialization of new products.

The Tredegar site reached this six-year landmark while delivering high quality general services day-to-day, but also with substantial expansion and investment programs within this period. Investments included the building of a contained manufacturing facility for the processing of highly potent molecules, new technologies such as roller compaction for products sensitive to heat and moisture, and Xcelodose® technology providing drug in capsule/vial for early stage development and First-in-Man studies. In addition to this, the site acquired a further 26,500 square feet of additional footprint in July 2016 to accommodate the continued expansion of its operations as an integrated service provider for its customers. This latest addition will facilitate the expansion of a number of key departments supporting continued business growth, including analytical and formulation development services.

Commenting on the safety track record, Norman Barras, Managing Director of PCI’s Tredegar site, said: “Remaining consistently accident-free at this site while undertaking significant construction programs and maintaining first-class operational delivery is a success that all of our employees deserve to be proud of. A record can only be reached through a site-wide appreciation and understanding of the importance of safety. All staff at our Tredegar facility played a vital role in the delivery of this significant safety record which we have now demonstrated for six years. It is their personal commitment to working in a safe and secure environment whilst managing the investment and expansion programs that has led to this outstanding achievement.

Bill Mitchell, PCI President and CEO, added: “Ensuring our customer’s products are developed and manufactured in the safest environment possible is intrinsic to the PCI business – for the benefit of our customers and staff alike. We have to provide our clients with absolute reassurance that products are processed safely and securely, whilst delivering on our duty of care responsibilities and ensuring the safety of all our employees. We have reached this safety milestone every year for six years; an accomplishment of this nature is a huge success for our business.

Posted on Categories News

Leave a Reply

Your email address will not be published. Required fields are marked *

sixteen − eleven =

Explore the PCI Process Phase by Phase


Swipe to explore the PCI Process


  • Formulation Development
  • Analytical development/characterisation


PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution


PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution


PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution


PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...